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Accommodation is controlled by the action of the ciliary muscle and mediated primarily by parasympathetic input through
postganglionic fibers that originate from neurons in the ciliary and pterygopalatine ganglia. During accommodation the pupil
constricts to increase the depth of focus of the eye and improve retinal image quality. Researchers have traditionally faced the
challenge of measuring the accommodative properties of the eye through a small pupil and thus have relied on pharmacological
agents to dilate the pupil. Achieving pupil dilation (mydriasis) without affecting the accommodative ability of the eye (cycloplegia)
could be useful in many clinical and research contexts. Phenylephrine hydrochloride (PHCl) is a sympathomimetic agent that is
used clinically to dilate the pupil. Nevertheless, first investigations suggested some loss of functional accommodation in the human
eye after PHCl instillation. Subsequent studies, based on different measurement procedures, obtained contradictory conclusions,
causing therefore an unexpected controversy that has been spread almost to the present days. This manuscript reviews and
summarizes the main research studies that have been performed to analyze the effect of PHCl on the accommodative system and
provides clear conclusions that could help clinicians know the real effects of PHCl on the accommodative system of the human eye.
1. Introduction
Accommodation is the change in optical power experienced
by the crystalline lens when the ciliary muscle contracts,
which allows the human eye to focus on near objects. The
eye uses this mechanism to attain clear vision across a
wide range of viewing distances. In an emmetropic eye,
accommodation is relaxed when the eye is focusing at distant
objects.This system is quite precise and its operation depends
on the integrity of both central and peripheral connections.
Accommodative dysfunction, which may be either excessive
or insufficient, can be caused by both systemic abnormalities
and focal pathologic processes.
Accommodation is controlled by the action of the ciliary
muscle, which is innervated by the autonomic nervous system
(ANS). This system influences numerous ocular functions
through parasympathetic and sympathetic innervations. The
control of accommodation ismediated primarily by parasym-
pathetic input [1], resulting in changes in the dioptric power
of the crystalline lens. Nevertheless, there exists evidence
supporting also a sympathetic innervation of ciliary muscle
[2].
Parasympathetic innervation is mediated through post-
ganglionic fibers that originate from neurons in the ciliary
and pterygopalatine ganglia [3]. Ciliary ganglion neurons
project to the ciliary body and the iris sphincter muscle to
control accommodation and pupil constriction, respectively.
Pupil dilation is controlled by the iris dilator muscle through
sympathetic innervation from postganglionic fibers, which
have their origin in neurons at the superior cervical ganglion.
During accommodation the pupil constricts to increase the
depth of focus of the eye and improve retinal image quality
[4]. This is part of the accommodation reflex, which includes
all the automatic and coordinated changes that occur in the
eye when viewing a near object: constriction of the pupil,
convergence of the eyes, and increased convexity of the
crystalline lens.
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Figure 1: Schematic diagram of both sympathetic and parasympathetic divisions from the autonomic nervous system, showing the main
receptors and neurotransmitters involved in each case.
As a consequence of the accommodation reflex, resear-
chers have traditionally faced the challenge of measuring the
accommodative properties of the eye through a small pupil
and thus have relied on pharmacological agents to dilate the
pupil. Achieving pupil dilation (mydriasis) without affecting
the accommodative ability of the eye (cycloplegia) could be
useful in many clinical and research contexts.
Phenylephrine hydrochloride (PHCl) is a sympath-
omimetic agent that is used clinically to dilate the pupil in
studies of accommodation, improving the ophthalmic instru-
ments’ performance when measuring through dilated pupils.
Nevertheless, investigations in humans have suggested some
loss of functional accommodation after PHCl instillation [5],
although there exists some controversy whether this loss is
due to direct action of PHCl on the ciliary muscle or due to
secondary optical factors associated with mydriasis.
To date, multiple researchers have used PHCl to achieve
mydriasis in human studies of accommodation without a
clear understanding of its effect on the ciliary muscle. The
aim of this manuscript is to review and summarize the main
research studies that have been performed to analyze the
effect of PHCl on the accommodative system and try to pro-
vide clear conclusions on this area that could help clinicians
know the real effects of PHCl on the accommodative system
of the human eye.
2. Methods of Literature Search
Review of the literature was conducted by searching in all
these databases: PubMed (US National Library of Medicine),
Web of Science (Thomson Reuters), Embase (Reed Elsevier
Properties SA), and Scopus (Elsevier BV). We limited our
search to English publications and peer reviewed scientific
reports. No date restriction was used in the electronic
searches. The date of the last electronic search was July 20,
2016.
In our literature search, we included a combination of
keywords, defining the following search criteria: “accommo-
dation” AND “phenylephrine OR PHCl”; we also screened
the reference lists of all eligible studies to ensure that any
relevant studies were not omitted.
After thoroughly searching the literature using these
criteria, a total number of 15 peer reviewed relevant articles
were analyzed. Of these 15 articles, 12 were research reports
using different subjective and objective measurement pro-
cedures, 1 was reporting an in vitro pharmacological test
using human ciliary muscle tissue, 1 was devoted to the
study of accommodation responses (AR) in anesthetized
rhesus monkeys, as they represent a proper model for
human accommodation, since they have an accommodative
mechanism and anatomy similar to that of humans, and the
last one was measuring human ciliary muscle size in vivo
using Optical Coherence Tomography (OCT) images. The
oldest peer reviewedmanuscript is dated 1959, while themore
recent one is from 2016.
3. Autonomic Control of Accommodation
The human body is equipped with a special branch of the
nervous system called the ANS, which automatically controls
and regulates the internal organs without any conscious
recognition by the organism. The ANS is divided into two
separate systems: the parasympathetic and the sympathetic
nervous system. The sympathetic nervous system is involved
in the stimulation of activities that prepare the body for
action, while the parasympathetic nervous system activates
tranquil functions. Sympathetic and parasympathetic divi-
sions typically work in opposition to each other. This natural
opposition is better understood as complementary in nature
rather than antagonistic. Figure 1 shows a schematic diagram
of both sympathetic and parasympathetic divisions, showing
the main receptors and neurotransmitters involved in each
one.
Autonomic control of accommodation is predominantly
parasympathetic and mediated by the action of acetylcholine
on muscarinic receptors [19]. Parasympathetic input to the
ciliary muscle mediates positive accommodation and meets
the need for rapid focusing changes because of its fast onset
of action (1-2 s). There is, however, clear evidence for a
small inhibitory sympathetic input [20] associated with the
parasympathetic response. Von Graefe, in 1855, was the first
to suggest that the ciliarymusclemust have a dual innervation
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by both parasympathetic and sympathetic nerves, as do the
iris [21] and the great majority of autonomically innervated
structures. Anatomic [22, 23], physiological [24, 25], and
pharmacologic [12, 26, 27] signs have later demonstrated this
hypothesis. In effect, anatomical and physiological literature
provides compelling evidence that sympathetic innervation
of human ciliary muscle produces inhibition of accommo-
dation that is relatively small and slow and a function of the
concurrent level of parasympathetic activity [20].
Sympathetic innervation to the ciliarymuscle is mediated
by the action of noradrenaline on two subclasses of postsy-
naptic receptors, 𝛼- and 𝛽-adrenoceptors. The stimulation of
these receptors, which are located on the cell surface, pro-
duces different physiological effects. Using adrenergic block-
ing agents, Kern and posteriorly van Alphen demonstrated
that human ciliary muscle was predominantly populated by
𝛽-adrenoceptors [19].
Pharmacological and nerve stimulation studies on animal
models (monkeys) suggest that the sympathetic input is more
relevant to tasks requiring sustained accommodation rather
than to tasks requiring a rapid change in the AR. The effects
of sympathetic inputs are small (less than 2 diopters (D)) and
slow (10–40 s) and the magnitude of sympathetic inhibitory
effects is related to the level of concurrent background
parasympathetic activity [28].
As Gilmartin et al. proposed [29], the role of sympathetic
innervation of the ciliary muscle may, for example, be to
attenuate the retention of accommodative tone induced by
periods of intense close work and thus reduce the risk of
latent posttask transitory pseudomyopic changes. The prin-
cipal characteristics of sympathetic inhibition were demon-
strated in their study: it is inhibitory and mediated by 𝛽-
adrenoceptors, is relatively small in magnitude, requires sus-
tained augmentation of concurrent accommodative activity
to become manifest, and operates in only a proportion of
individuals. In particular, and as an example, 25–35% of
young adult subjects have access to sympathetic inhibitory
accommodative control [30, 31]. Absence of sympathetic
facility has no significant effect on the function of the accom-
modative system under closed-loop visual stimuli. Besides,
under high-contrast closed-loop conditions, the sympathetic
branch of accommodative control fails to have a significant
effect on manifest oculomotor responses [30].
However, it is important to highlight that when inter-
preting results of studies involving agents from the ANS, the
complexity of the autonomic structures and their functions,
as well as the potential interactions between them, should be
taken into account [19].
4. Phenylephrine Hydrochloride (PHCl)
PHCl is a selective𝛼-adrenergic receptor (or𝛼-adrenoceptor)
agonist used primarily as a decongestant, as an agent to
dilate the pupil, and to increase blood pressure. It is used
as a mydriatic agent, in the form of eye drops, to dilate the
iris before eye surgery or eye examinations. PHCl 2.5% is
normally used for fundus examination, while 10% concen-
tration is used therapeutically to break posterior synechiae
(a)
(b)
Figure 2: Anterior segment image of the human eye taken by
Optical Coherence Tomography by means of the Visante Omni
System (Carl Zeiss AG, Oberkochen, Germany). (a) Under myosis
conditions (constriction of the pupil). (b) Under mydriatic condi-
tions (dilation of the pupil).
and pupillary block [5]. Figure 2 shows two OCT anterior
segment images of the human eye taken with the Visante
Omni System (Carl Zeiss AG, Oberkochen, Germany) under
myosis and mydriasis.
To understand the effect and the mechanism of action
of PHCl, it could be useful to state that adrenoceptors are a
class of G protein-coupled receptors that are targets of the
catecholamines, especially norepinephrine and epinephrine,
also known as noradrenaline and adrenaline, respectively.
Many cells possess these receptors, and the binding of a
catecholamine to the receptor will generally stimulate the
sympathetic nervous system. On the other hand, an agonist
is a chemical compound capable of simulating the effect
of a natural substance produced by our own body. The
substances naturally produced by our body act on cellular
receptors. The agonist is not the original substance produced
by our body, but it acts similarly occupying the receptors and
activating them, imitating or even enhancing therefore the
effect produced by the natural substance. On the contrary,
an antagonist mimics the natural substance to take its place
in the receptor. Thus the original substance cannot act as
its site is occupied by the antagonist. Figure 3(a) shows
a schematic of the behaviour of agonist and antagonist
chemical compounds.
Phenylephrine can be synthetically manufactured, and it
is usually found in hydrochloride form as PHCl, which is
an acid salt resulting from the reaction of hydrochloric acid
with phenylephrine. Converting insoluble phenylephrine
into hydrochloride is a commonway tomake it water-soluble,
which allows for a quick absorption into the bloodstream.
Phenylephrine has both chemical and pharmacological simi-
larities to norepinephrine [32]. The skeletal formulae of both
chemical compounds are shown in Figure 3(b).
A characteristic quality of phenylephrine is the distinctly
expressed selectivity to 𝛼-adrenoceptors. Therefore, as PHCl
is primarily 𝛼-adrenoceptors agonist, it should have little
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Figure 3: Agonist versus antagonist behaviour. The substances naturally produced by our body act on cellular receptors. The agonist is not
the natural substance, but it acts similarly occupying the receptors and activating them, imitating or even enhancing therefore the effect
produced by the natural substance. On the contrary, an antagonist mimics the natural substance to take its place in the receptor, blocking
thus the cellular activity.
influence on the 𝛽-adrenoceptors in ciliary muscle. In other
words, a drug like PHCl that is a pure 𝛼-adrenoceptors
agonist would be expected to produce pupil dilationwith little
or no influence in accommodation [21]. But it is, however,
possible that PHCl may alter ciliary muscle size or function
via 𝛼-adrenoceptors [17].
AK-Dilate, Altafrin, Cyclomydril, Mydfrin, Neo-
frin, Ocu-Phrin, and Prefrin are some of the available
brand names prepared as sterile topical ophthalmic solutions
containing PHCl.
5. Resting State of Accommodation
In an emmetropic eye, the resting state of accommodation
(RSA) is usually at an intermediate distance of about one
meter and not at infinity [21]. This state can be induced
either by being in total darkness or by viewing an empty field
under uniform illumination. Therefore, in a normal person
at rest, the ciliary muscle exerts 1 D of accommodation.
Dual innervation of the ciliary muscle with a balanced tone
might be involved in this myopic shift. Therefore, both
parasympathetic and sympathetic input to the ciliary muscle
are important with regard to determining an individual’s
RSA [20]. As for the RSA the magnitude of parasympathetic
innervation is small (as the accommodation response is
around 1D), and, taking into account that sympathetic
innervation operates in only a proportion of individuals and
as a function of the concurrent level of parasympathetic
activity, the sympathetic input may be limited.
The RSA is referred to as “tonic accommodation,”
although the term “dark focus” is also used. If an object is
beyond the RSA, effort to relax accommodation would need
to be exerted. Contrarily, if an object is nearer than the RSA,
an effort to accommodate must be made.
Previous research has demonstrated that the AR is
dependent on subject and target characteristics such as pupil
size [33, 34], age [35], luminance [36], and spatial frequency
[37, 38]. As already stated, in the absence of adequate visual
stimuli accommodation adopts an intermediate resting posi-
tion [39, 40].
6. Effects of Phenylephrine Hydrochloride
(PHCl) on Accommodation
This section includes the main conclusions that can be
outlined from the main research studies that have been
performed to try to elucidate the possible effects of PHCl on
the accommodation abilities of the human vision system.This
literature summary is presented in an essentially chronolog-
ical order, with the only aim of facilitating comprehension
and understanding of the controversy caused in this field
throughout the last years.
All the main results that arise from the research reports
that have been reviewed are summarized in Table 1.Themain
outcomes of each report are compiled in a different row in
this table, including
(i) the first author of the report and the year in which it
was published,
(ii) the number of patients included in the study and their
age range,
(iii) the number of drops of PHCl instilled in each patient
and its concentration in %,
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(iv) a summary of themeasurement procedure tomeasure
the AR,
(v) the observed effect after PHCl instillation, as it is
outlined by the authors of the report.
When reviewing the literature in the field, it is important
to consider the PHCl concentration and the number of drops
and the instillation protocol (i.e., time between drops and
time from last drop to starting the experiment), as all of them
are able to influence the obtained results.
While reading this section, the reader is kindly referred
to each row of Table 1 to review the main conclusions of
each report that varies in the measurement procedure and
conclusions outlined.
Biggs and colleagues [6] were the first to report that
eight drops of 10% solution of PHCl, instilled intensively
at a rate of one drop every two minutes, reduced the
amplitude of accommodation (AA) by 0.66D on average.
They employed two different procedures to study the changes
in accommodation by this drug. The first was based on the
use of a stigmatoscope, which presented a single spot of
light viewed on an ophthalmic letter chart. By placing lenses
before the eye and requiring the observer to resolve the details
of the letter chart while adjusting the stigmatoscope to its
sharpest focus, they were able to measure the AR to a variety
of accommodative stimuli. The second procedure was based
on the use of a subjective Badal optometer to measure the
near point of accommodation (NPA). This system has the
advantage that changes in position of the target have no effect
at all upon either its brightness or its apparent size. In both
procedures, a 2.0mm artificial pupil was used. The effects
of the drug on the accommodation were noted 30 minutes
after instillation began and had disappeared in two hours.
They concluded that intensive topical administration of PHCl
caused only a slight recession of the near point, while when
the drops were administered once every 15 minutes, it was
difficult to demonstrate any effect on accommodation.
Leibowitz and Owens [7] measured, before and after
administration of two drops of 10% PHCl, the AR and the
dark focus of accommodation with a laser optometer that
incorporated the Badal principle. In this technique, a speckle
pattern, produced by reflecting the diverged beam of a low-
output laser from the surface of a slowly rotating drum, is
superimposed in the observer’s visual field by means of a
beam splitter. If the eye is overaccommodated with respect
to the optical distance of the drum’s axis, the speckle pattern
appears to move in the same direction as the near surface
of the drum; if under-accommodated, it appears to move in
a direction opposite to the near surface of the drum. When
the axis is at an optical distance conjugated to the retina,
the speckle pattern appears stationary. They included seven
subjects aged 18 to 34: four myopes, two hyperopes, and
one emmetrope, all of them wearing their normal optical
corrections. The measurements of the AR and the dark focus
of accommodation were repeated every 15 minutes for three
hours following administration of the drug.The subjects were
instructed to fixate carefully a defined target on an outdoor
scene for measuring the far point of accommodation (FPA)
and to relax their eyes formeasuring the dark condition. Pupil
dilation was observed 25 minutes after introduction of the
drug. Therefore, changes of accommodation due to depth of
field or spherical aberration would be expected to occur at
this time. Nevertheless, no systematic change of either the far
point of accommodation or the dark focus was evident in the
results.
Eight years later, Garner and coworkers [8] alsomeasured
the accommodative state with a laser optometer based on
the Badal principle through the analysis of moving speckle
patterns. They used a 6/9 Snellen letter with a background
luminance of 3 cd/m2 to measure the FPA. The NPA was
determined as the closest distance to which a line target
could be moved towards the eye without noticeable blur.
And the RSA was determined with the laser optometer after
5 minutes in complete darkness. Two drops of PHCl 10%
were instilled in each eye. Three subjects were included in
the study, and the FPA, NPA, and RPA were determined at
approximately hourly intervals for the duration of each trial.
Thedrug treatment producedmydriasis and reduced theNPA
in all subjects by 2.5–3.0D under natural pupils. A typical
accommodative lag of 1 D was exhibited by all subjects. The
RPA varied between 2.0 and 2.5D.The FPA and RPA showed
no significant variations during the course of changes in pupil
diameters.
Zetterstro¨m [9] studied the influence of different concen-
trations of PHCl on the accommodation abilities of 10 healthy
volunteers ranging in age from 22 to 29 years. Lenses were
placed in front of the eye corresponding to the refraction for
far distance and with the addition of a −3.0D lens to move
the near point to a point which allowed a proper distance
per dioptric unit in the determination of accommodation. All
measurements were made using a 2mm artificial pupil. The
test subject looked at the smallest optotype on a RAF near-
point rule (Clement Clarke Ltd.), beginning from a distance
of half a meter and then slowly moving the text towards the
eye until the text became blurred. The determination was
performed by the examiner, and the mean value of three
determinations was calculated. All volunteers were tested
without the instillation of PHCl and after the instillation of
one drop of PHCl 0.1%, one drop of PHCl 1%, and one drop
of PHCl 10% with a wash-out of at least 2 days between
experiments. As a result, the mean values of accommodation
in diopters showed a fairly good correlation between dose
and decrease in accommodation. Statistical analysis revealed
that there were significant differences in the ability to accom-
modate between the three different solutions. Nevertheless,
great individual differences were found. In particular, two
out of the 10 subjects were extremely sensitive. For them, the
accommodation was reduced by 5.6 and 8.8 D after one drop
of 10% PHCl. The author concluded that PHCl had an effect
on accommodation and that this effect could amount to 2 or
3D.
Mordi and colleagues [10] analyzed the mydriatic and
cycloplegic effects of either cyclopentolate 0.1% or PHCl 10%
over a period of up to 6 hours after drug instillation. They
included five subjects aged between 25 and 43 years. Two
drops of PHCl were instilled separated by 2 minutes, and
the monocular static and dynamic AR were assessed with
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an infrared optometer. High-contrast targets were employed
with target-eye vergence of −5.0, −4.0, −3.0, −2.0, and
−1.0D. A supplementary lens allowed an additional effective
vergence of 0.0D to be presented. Target size was scaled so
that the smallest detail of each target subtended the same
visual angle at all object distances. The authors characterized
the dynamic change in response to an abrupt change in target
vergence in terms of two temporal parameters, the reaction
time and the response time. The reaction time is defined as
the time elapsing between the stimulus change and the start
of the corresponding response, and the response time is the
time taken to complete the response.The reaction times were
little influenced by the drug used. Nevertheless, both drugs
increased the response time, with cyclopentolate having the
larger effect. Besides, considerable intersubject variations
in response characteristics were observed particularly with
respect to the initial direction of response. Regarding the
effects of the drugs upon the steady state response levels, both
drugs had considerable effects, and these effects varied as a
function of time. With 10% PHCl, the magnitude of the slope
of the response/stimulus curve was reduced. According to the
authors, this slope reduction was obviously closely related to
the recession of the near point found by Garner et al. [8] and
the reduction in the AA found by Zetterstro¨m [9] with the
same drug. The authors concluded that neither drug can be
considered to be an “ideal” mydriatic, since each produces
cycloplegic effects, including a slowing of the dynamics of the
AR, a recession of the near point, and a reduction in the slope
of theAR/stimulus curve, which have approximately the same
temporal characteristics as the mydriatic effects.
In an additional report, Mordi and coworkers [11] stated
the conclusions of a different study to analyze the effect of
the topical instillation of PHCl on accommodation. Factors
considered in this study were iris colour and the influence
of the prior application of a topical anesthetic (proparacaine
hydrochloride) before PHCl instillation. Baseline measure-
ments of AA, refractive status, and pupil diameter were
obtained before any drops were instilled in the eyes of 10
Caucasian subjects all within the age range of 20 to 26 years.
Each subject received 1 drop of topical anesthetic in 1 eye.
Three minutes later the subjects were instilled with 1 drop
of PHCl 2.5% in each eye. The AA was measured while
the subject wore the appropriate optical correction for his
or her distance refractive error. Donders’ push-up method
[41] was used to measure the amplitude while the subject
read the words in the 0.62M test target at 40 cm. Amplitude
measurements were repeated every 5min until the subject’s
minimum value was reached, and then the measurements
were taken every 20min until 50% recovery of the amplitude
occurred. Pupil size was measured under the same lighting
conditions.The authors obtained that PHCl 2.5% does inhibit
accommodation by about 15% when used alone and by
over 25% when preceded by anesthetic instillations. Besides,
anesthetizing the cornea improves the ability of PHCl to dilate
the pupil. The authors concluded that prior application of an
anesthetic prolongs both the depression effect of PHCl on the
accommodation and the mydriatic effect, in eyes with either
lightly or more heavily pigmented irides.
Two years later, the possible influence of PHCl in the
activity of the ciliary muscle was studied using in vitro
samples. Zetterstro¨m and collaborator [12] studied the in
vitro pharmacological characteristics of adrenoceptors of the
human ciliarymuscle.They used human tissue obtained from
30 eyes which had been enucleated 6–24 hr after death and
used previously for corneal transplantations. By means of
attaching strips of the meridional and circular portion of the
ciliary muscle to a tension gauge in an organ bath they were
able to monitor isometrically the effect of drugs added to the
perfusionmedium. As a result, ciliarymuscle from only three
out of eight eyes relaxed in responses to PHCl.
Later on, Gimpel et al. [13] performed a large sample
study over a period of 5 years to investigate the effects
of PHCl 2.5% on the subjective AA in 160 healthy eyes
without the prior use of a topical anesthetic. The NPA was
measured monocularly by Donders’ push-up method: the
best acuity target was slowly moved towards the test eye until
it was blurred; then the distance of the target from the eye
and estimated spectacle plane was converted into dioptric
equivalents. All measurements were assessed through the
natural pupil under ambient illumination of around 150 lux.
After the instillation of a single drop of PHCl 2.5% into
the test eye, measurements were repeated for the test eye
and contralateral eye every 5min for 30min and then every
10min until a total time period of 90min. By 30min, a net
decrease in the subjectively assessed average AA of 1.22D
occurred, that is, a net reduction of 10.9% compared to the
initial baseline readings. At 60min, a reduction of 1.39D
was recorded, although large standard deviations about the
mean values were obtained, reflecting the fact that some
subjects showed a reduction in amplitude, and some showed
no change, while a few showed an increase in amplitude.This
study clearly confirmed that PHCl could reduce the AA as
assessed subjectively.
Four years later, Eyeson-Annan and colleagues [14] per-
formed a study to identify any significant difference between
maximum pupil dilation and accommodation after PHCl
10% alone and PHCl 10% combined with tropicamide 1%. In
the first dilation regimen, one drop of 0.4% oxybuprocaine
hydrochloride was instilled into the right eye and then the
left eye of each subject, followed 30 seconds later by one drop
of PHCl 10% and 5 minutes later by a second drop and a
third drop 5 minutes later. Oxybuprocaine hydrochloric acid
was instilled into the subjects’ eyes to improve absorption of
the PHCl. In the second dilation regimen, one drop of 0.4%
oxybuprocaine hydrochloride was instilled into the right eye
and then the left eye of each subject, followed 30 seconds
later by one drop of PHCl 10% and followed 30 seconds later
by one drop of tropicamide 1%, repeating the instillation of
these two chemical agents 5 and 10 minutes later.The authors
tested also a reversal regimen to counteract the effects of
the mydriasis, by instilling one drop of 0.4% oxybuprocaine
hydrochloride into the right eye and then the left eye of each
subject, followed 30 seconds later by a drop of thymoxamine
hydrochloride 0.5%. A total of 47 subjects participated in the
study. The subjects’ AA was measured binocularly using a
near-reading chart at the 0.7 line. Two accommodation levels
weremeasured: (1) the reading distance and (2) the near-chart
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distance at which the letters began to blur. Those subjects
who wore glasses were instructed to use them for all of the
tests. Accommodation was measured using the near-reading
chart just before dilation, 20 and 40min after instillation of
the dilating drops. Reversal regimenwas instilled 40min after
instillation of the dilating drops, and measurements were
taken again 40min after the instillation of the reversal drops.
The authors concluded that accommodation was impaired
significantly more after PHCL and tropicamide than after
PHCl alone. Thus, PHCl alone had no significant effect on
the AA of the subjects, reporting mean values of 1.60D
and 1.57D at 20min and 40min after instillation of dilating
drops, respectively, in comparison with a baseline value of
1.53D. However, tropicamide in combination with PHCl
had significantly decreased the mean AA of the subjects,
obtaining values of 0.70D and 0.80D at 20min and 40min
after dilating drops. Measuring 40minutes after reversal with
thymoxamine resulted in a mean accommodation value of
1.12D, which still was significantly lower than the baseline
value.
Next report was presented by Culhane and coworkers [2],
who made a study to identify the action of 𝛼-adrenoceptors
on the closed-loop AR. Ten visually normal subjects par-
ticipated in the study, in which monocular temporal AR
were measured objectively using a continuously recording
dynamic tracking infrared optometer. They used a visual
Badal stimulus deflector system to change optically the ver-
gence (apparent distance) of the accommodation stimulus,
which allowed stimulus vergence to be modulated without
changing stimulus size, position, or luminance. A 4-mm
artificial pupil was imaged in the subject’s natural entrance
pupil to remove any variation in performance caused by
changes in depth of focus due to pupil dilation.The dynamics
of the AR to sinusoidal (0.05, 0.1, 0.2, 0.3, 0.4, and 0.6Hz) and
stepwise (0.05Hz)modulations in target vergence over a 2- to
4-D range were investigated before and after (approximately
55 minutes) the instillation of 1 drop of PHCl 2.5% into
the lower fornix. The authors obtained a significant increase
in accommodative gain at low- and mid-temporal frequen-
cies, although no significant difference in phase lag was
detected. These results showed that additional stimulation
of the 𝛼-inhibitory receptors with PHCl 2.5% allowed the
accommodative system to track more accurately at low-
and mid-temporal frequencies, optimizing then the AR.
According to the authors, as an optimumbalance between the
parasympathetic and sympathetic control of accommodation
is necessary to respond to temporal variations in target
distance and to prevent adaptation after sustained near vision,
these results suggested that the sympathetic component of
the response is necessary to provide maximum negative
accommodation.
In 2002, Do and coworkers [15] measured subjectively
the AA with the push-up technique and objectively with
the Hartinger Coincidence Refractometer in a set of 10
subjects. They also assessed accommodative dynamics with
an infrared optometer (PowerRefractor).Measurements were
taken before and at 15-minute intervals for 90 minutes after
instillation of PHCl 2.5%. In this study, all subjects showed
a decrease in AA measured with the subjective push-up
technique (mean 17%, max decrease at 30–90 minutes) after
instillation of PHCl. Nevertheless, AA measured objectively
with the Hartinger Coincidence Refractometer showed no
decrease in maximum AA. According to the authors, this is
likely to occur due to mydriasis of the pupil and decreased
depth of focus rather than sympathetic inhibition of the
ciliarymuscle. Regarding dynamicmeasurements, some sub-
jects showed a decrease in peak velocity of accommodation,
suggesting that PHCl should not be used to dilate the pupil
when testing accommodative dynamics.
The effects of PHCl 10% on pupil diameter and accommo-
dation were then studied in rhesus monkeys [5], as they rep-
resent a unique model for human accommodation because
they have high AA and an accommodative mechanism and
anatomy similar to that of humans. The purpose of this
study, conducted by Ostrin and Glasser, was to determine
whether PHCl affects Edinger-Westphal- (EW-) stimulated
accommodation in rhesus monkeys. Static and dynamic EW-
stimulated AR were studied in five iridectomized rhesus
monkeys before and after phenylephrine instillation. An elec-
trode implanted in the EWnucleus of themonkeys’ midbrain
was used to stimulate the open-loop accommodation. This
method allows for an AR that is not affected by pupil size
or visual feedback and that can be rigorously controlled by
stimulus amplitude, differentiating so effects of PHCl on
the ciliary muscle versus effects due to secondary optical
factors resulting from mydriasis. A Hartinger Coincidence
Refractometer was used to measure the AA, and infrared
photorefraction was used to assess the dynamic AR. After
the baseline recordings, two doses of 0.1mL PHCl 10% were
instilled topically, separated by 2minutes.The effects of PHCl
on dynamic accommodation were established in terms of
peak velocities of accommodation and disaccommodation.
The authors obtained post-PHCl AA similar to pre-PHCl
amplitudes, whereas dynamic analysis of the AR showed
linear peak velocity versus AA relationships that were not
statistically different before and after PHCl. The authors
of this study concluded that although there are individual
differences before and after the instillation of PHCl, these
differences are not systematic, and within the resolution of
the methods there are no significant effects of PHCl on
AA, dynamics, or RSA. Therefore, adrenergic stimulation
causes strong pupil dilation in noniridectomized monkey
eyes but does not affect EW-stimulated AA or dynamics in
anesthetized, iridectomized rhesus monkeys.
Recently, in 2012, Sarkar et al. [16] performed a study
to determine the combined impact of PHCl concentration
and pupil size on the static and dynamic characteristics
of accommodation of sixteen visually normal adults. The
study had four different conditions regarding the PHCl
concentration (without PHCl and with PHCl 2.5%, PHCl
5%, and PHCl 10%) and five viewing conditions (viewing
with natural pupils and with 8, 6, 4, and 1mm diameter
artificial pupils). A total of three drops were instilled, one
drop every 15min, and the experiment started 1 hour after
instillation of the first drop. Subjects watched a high-contrast,
high spatial frequency visual target displayed on one of the
two liquid-crystal display screens that were placed at 67 and
33 cm, respectively, in front of the subject. The visual target
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was electronically switched between the two screens, once
every 4 s, thereby creating an accommodative demand of
1.5 D. The viewing was monocular while AR was recorded
bilaterally.They measured a peak velocity of accommodation
with no PHCl significantly larger than those with all three
concentrations of PHCl, while the data for the three drug
concentrations were not significantly different from each
other. Overall, their results indicated that PHCl had a small
but statistically significant negative impact on the response
magnitude and peak velocity of accommodation but not
that of disaccommodation. There appeared to be no obvious
interaction between drug concentration and pupil size on
accommodative performance, suggesting that the pharmaco-
logical effect of PHCl and the optical effect of increased pupil
diameter following PHCl instillation both contribute towards
the reduction in accommodative performance. According to
the authors, the reduction in accommodative performance
is modest and does not carry a large clinical significance,
meaning that PHCl could therefore be used to achieve pupil
mydriasis without dramatically hampering accommodation.
In the same year Richdale et al. [17] conducted the first
study to examine the effect of PHCl on the human ciliary
muscle in vivo. They aimed to determine if, in response to
topical administration of 2.5% PHCl, there were changes
in (1) the dimensions of the ciliary muscle and (2) the
accommodative contraction of the ciliarymuscle.TheVisante
Anterior Segment OCT (Carl Zeiss Meditec, USA) was used
to image the ciliary muscle in relaxed and accommodated
states (0 and 4D targets) in a set of 25 subjects. Pupil size and
accommodative function were also measured. AR at 0 and
4D stimulus levels wasmeasured subjectively and objectively.
For subjective testing,maximummonocular accommodation
was determined using the push-up to blur technique and a
1mm letter target. Objective static AR was measured with
the Grand Seiko WV 500 Auto-Refractor (Grand Seiko Ltd.,
Japan) and a 2mm letter target on a Badal lens track. Mea-
surements were repeated 30 minutes after topical adminis-
tration of one drop of 1% proparacaine and one drop of PHCl
2.5%. Proparacaine was used both to increase patient comfort
and because application of proparacaine has been shown to
increase the effect of PHCl, especially in patients with dark
irides [11]. They obtained that the maximum subjective AR
was reduced by about 1 D following instillation of PHCl,
although the drug did not affect the objectively measured
AR. Besides, the cross-sectional ciliary muscle dimensions
and contractility to a 4D stimulus were not altered by the
instillation of PHCl 2.5%. This finding suggests, according
to the authors, that there is no physiological effect on the
accommodative system due to the effect of PHCl.
The last contribution to the field was dated 2016. Bernal-
Molina and colleagues [18] tested the hypothesis that changes
in accommodation after PHCl instillation are due to changes
in optics and not to changes in the function of the ciliary
muscle. They studied the effect of PHCl both on static and
on dynamic accommodation. The effect on static accommo-
dation was assessed for 8 eyes by computing the stimulus-
response curve from the wavefront obtained at different
vergence. Measurements were taken with the IRX3 commer-
cial aberrometer (Imagine Eyes, France) for natural pupils
before and after instillation of 2 drops of PHCl 10%. From
these curves, the authors obtained the objective AA and
the AR up to 6D. The effect of phenylephrine on dynamic
accommodation was assessed for 6 eyes by measuring the AR
at 10Hz to a sinusoidally moving stimulus seen through a
3-mm artificial pupil. The stimulus moved between 1D and
3D from the subject’s far point at 0.2Hz. Measurements were
taken with a custom-made optical system, and the authors
computed the gain and phase of the dynamic responses.
AR was calculated taking into account the effects of higher-
order aberrations (minimum RMS refraction) and without
them (paraxial refraction). The authors obtained that, for
static accommodation with the minimum RMS calculation
of AR, the mean AA (and 95% confidence interval) changed
after PHCl instillation by 0.51 D (0.14D, 0.88D). The change
of the AR at a 6D of accommodative demand was 1.00D
(0.64D, 1.36D).However, the values obtained for paraxial AR
were −0.20D (−0.55D, 0.15D) and 0.22D (−0.20D, 0.64D),
respectively. For dynamic accommodation, the authors found
a mean difference in the AR gain of 0.09D (−0.10D, 0.19D)
with minimum RMS and −0.08D (−0.14D, 0.02D) for par-
axial refraction. The authors concluded that whereas they
found a clear, statistically significant decrease in AR after the
instillation of PHCl, they did not find any effect on static
and dynamic accommodationwhen higher-order aberrations
were not taken into account in the calculation of AR. Accord-
ing to the authors, as paraxial refraction depends mainly
on the ciliary muscle, its function seems to be unaffected
by PHCl according to their results. Therefore, differences in
reported effects of PHCl may be due to the methods used to
calculate the AR.
7. Conclusions
First investigations suggested some loss of functional accom-
modation in the human eye after PHCl instillation. Subse-
quent research studies, based on different measurement pro-
cedures, obtained contradictory conclusions, causing there-
fore an unexpected controversy that has been spread almost
to the present days.
This manuscript reviews the main research studies that
have analyzed the effect of PHCl on the accommodative
system of the human eye and summarizes their main conclu-
sions, describing the different measurement procedures that
have been used in each one.
As a brief summary, it is worth noting that AR measure-
ments after PHCl instillation performed by subjective meth-
ods such as Donders’ push-up technique obtained significant
reductions in the AA of up to several diopters. Nevertheless,
the experiments based on objective measurement methods,
such as the study of the ciliary muscle size by OCT images
or the use of an electrode implanted in monkeys’ midbrain to
stimulate accommodation without the feedback giving by the
pupil size, conclude that there are no significant effects due to
PHCl on AA, dynamics, or RSA.
All in all, it seems that the most accepted conclusion
is that subjective measurements are affected by mydriasis
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produced by PHCl instillation, in the sense that the alter-
ations measured on accommodation are likely to occur due
to optical changes in the eye following pupil dilation.The iris
dilates after PHCl, reducing the depth of field and affecting
thus the subjects’ perception of blur. On the contrary, objec-
tive methods, which are able to separate accommodation
measurements from the optical effects of the pupil dilation on
the perception of the image, conclude that PHCl instillation
has no effect over the accommodative abilities of the human
eye.
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